AI assistant
Sending…
RESMED INC — Director's Dealing 2022
Nov 19, 2022
30071_dirs_2022-11-18_dd9ca1e2-e9db-455f-bce9-bcb43d15ee45.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-16
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-16 | ResMed Common Stock Options | $224.58 | A | 36569 | Acquired | 2029-11-16 | ResMed Common Stock (36569) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3880 | Indirect |
| ResMed Common Stock | 414024 | Direct |
Footnotes
F1: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.
More from RESMED INC
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29
Director's Dealing
2026
Jan 9